ByBug

At ByBug, we are redefining how the world produces therapeutic proteins. Our breakthrough lies in a new paradigm of biomanufacturing: a platform powered by genetically enhanced Hermetia illucens larvae engineered to produce recombinant proteins and veterinary therapeutics with unprecedented efficiency.

By transforming insect larvae into next-generation biofactories, we enable a production model that is 100× more cost-effective and up to 150× more sustainable than conventional systems—unlocking a future where life-saving and life-enhancing biomolecules can be manufactured at scale, with minimal environmental impact.

We are not just improving biomanufacturing.
We are reinventing it.